JTB SRATEGIES

Lobbying for MANAX RUTSON CLINICAL DEVELOPMENT LLC · Healthcare Private Equity

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New York · $20,000.00 income · posted Jul 16, 2025

Lobbying activity 1

Health Issues

Rare disease drug development reciprocity across trusted nations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem